Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer.
Traphagen NA, Schwartz GN, Tau S, Jiang A, Hosford SR, Goen AE, Roberts AM, Romo BA, Johnson AL, Duffy EK, Demidenko E, Heverly P, Mosesson Y, Soucy SM, Kolling F, Miller TW.
Traphagen NA, et al. Among authors: kolling f.
bioRxiv [Preprint]. 2023 Mar 17:2023.03.16.532956. doi: 10.1101/2023.03.16.532956.
bioRxiv. 2023.
PMID: 36993590
Free PMC article.
Updated.
Preprint.